{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:51:35Z","timestamp":1790247095714,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41431-020-0624-x","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T12:22:41Z","timestamp":1587730961000},"page":"1231-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot"],"prefix":"10.1038","volume":"28","author":[{"given":"Susanna","family":"Croci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Lucia","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Capitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5634-031X","authenticated-orcid":false,"given":"Elisa","family":"Frullanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Lamacchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Tita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Giliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ciabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Furini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Lo Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-6901","authenticated-orcid":false,"given":"Anna Maria","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-1846","authenticated-orcid":false,"given":"Silvestro Giovanni","family":"Conticello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Renieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"624_CR1","doi-asserted-by":"publisher","first-page":"e01250","DOI":"10.1002\/brb3.1250","volume":"9","author":"FF Operto","year":"2019","unstructured":"Operto FF, Mazza R, Pastorino GMG, Verrotti A, Coppola G. Epilepsy and genetic in Rett syndrome: a review. Brain and Behav. 2019;9:e01250.","journal-title":"Brain and Behav"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007;56:422\u201337.","journal-title":"Neuron"},{"key":"624_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg1878","volume":"7","author":"T Bienvenu","year":"2006","unstructured":"Bienvenu T, Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet. 2006;7:415.","journal-title":"Nat Rev Genet"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/YCO.0000000000000389","volume":"31","author":"F Ehrhart","year":"2018","unstructured":"Ehrhart F, Sangani NB, Curfs LM. Current developments in the genetics of Rett and Rett-like syndrome. Curr Opin Psychiatry. 2018;31:103\u20138.","journal-title":"Curr Opin Psychiatry"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"170216","DOI":"10.1098\/rsob.170216","volume":"8","author":"SM Kyle","year":"2018","unstructured":"Kyle SM, Vashi N, Justice MJ. Rett syndrome: a neurological disorder with metabolic components. Open Biol. 2018;8:170216.","journal-title":"Open Biol"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jmg.2006.045260","volume":"44","author":"H Archer","year":"2007","unstructured":"Archer H, Evans J, Leonard H, Colvin L, Ravine D, Christodoulou J, et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X\u2010chromosome inactivation. J Med Genet 2007;44:148\u201352.","journal-title":"J Med Genet"},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/epi.12941","volume":"56","author":"A Nissenkorn","year":"2015","unstructured":"Nissenkorn A, Levy-Drummer RS, Bondi O, Renieri A, Villard L, Mari F, et al. Epilepsy in Rett syndrome-lessons from the Rett networked database. Epilepsia 2015;56:569\u201376.","journal-title":"Epilepsia"},{"key":"624_CR8","first-page":"103","volume":"5","author":"VA Cuddapah","year":"2015","unstructured":"Cuddapah VA, Nwaobi SE, Percy AK, Olsen ML. MeCP2 in the regulation of neural activity: Rett syndrome pathophysiological perspectives. Degener Neurol Neuromuscul Dis. 2015;5:103.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"624_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1044-7431(03)00026-5","volume":"22","author":"DR Cohen","year":"2003","unstructured":"Cohen DR, Matarazzo V, Palmer AM, Tu Y, Jeon OH, Pevsner J, et al. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci. 2003;22:417\u201329.","journal-title":"Mol Cell Neurosci"},{"key":"624_CR10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.1153252","volume":"320","author":"M Chahrour","year":"2008","unstructured":"Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008;320:1224\u20139.","journal-title":"Science"},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315:1143\u20137.","journal-title":"Science"},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/ajmg.a.33184","volume":"152","author":"MB Ramocki","year":"2010","unstructured":"Ramocki MB, Tavyev YJ, Peters SU. The MECP2 duplication syndrome. Am J Med Genet Part A. 2010;152:1079\u201388.","journal-title":"Am J Med Genet Part A"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1101\/gad.320325.118","volume":"32","author":"MV Koerner","year":"2018","unstructured":"Koerner MV, FitzPatrick L, Selfridge J, Guy J, De Sousa D, Tillotson R, et al. Toxicity of overexpressed MeCP2 is independent of HDAC3 activity. Genes Dev. 2018;32:1514\u201324.","journal-title":"Genes Dev"},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ejhg.2014.81","volume":"23","author":"G Livide","year":"2015","unstructured":"Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, et al. GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. Eur J Hum Genet. 2015;23:195.","journal-title":"Eur J Hum Genet"},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/ejhg.2015.216","volume":"24","author":"T Patriarchi","year":"2016","unstructured":"Patriarchi T, Amabile S, Frullanti E, Landucci E, Rizzo CL, Ariani F, et al. Imbalance of excitatory\/inhibitory synaptic protein expression in iPSC-derived neurons from FOXG1+\/\u2212 patients and in foxg1+\/\u2212 mice. Eur J Hum Genet. 2016;24:871.","journal-title":"Eur J Hum Genet"},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.yexcr.2018.05.001","volume":"368","author":"E Landucci","year":"2018","unstructured":"Landucci E, Brindisi M, Bianciardi L, Catania LM, Daga S, Croci S, et al. iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated \u03b1-tubulin defect which improves after iHDAC6 treatment in Rett syndrome. Exp Cell Res. 2018;368:225\u201335.","journal-title":"Exp Cell Res"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","volume":"109","author":"G Gasiunas","year":"2012","unstructured":"Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9\u2013crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci. 2012;109:E2579\u2013E2586.","journal-title":"Proc Natl Acad Sci"},{"key":"624_CR18","doi-asserted-by":"publisher","first-page":"52541","DOI":"10.18632\/oncotarget.9646","volume":"7","author":"FA Khan","year":"2016","unstructured":"Khan FA, Pandupuspitasari NS, Chun-Jie H, Ao Z, Jamal M, Zohaib A, et al. CRISPR\/Cas9 therapeutics: a cure for cancer and other genetic diseases. Oncotarget. 2016;7:52541.","journal-title":"Oncotarget"},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00204-015-1504-y","volume":"89","author":"A Pellagatti","year":"2015","unstructured":"Pellagatti A, Dolatshad H, Valletta S, Boultwood J. Application of CRISPR\/Cas9 genome editing to the study and treatment of disease. Arch Toxicol. 2015;89:1023\u201334.","journal-title":"Arch Toxicol"},{"key":"624_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuron.2017.10.004","volume":"96","author":"J Nishiyama","year":"2017","unstructured":"Nishiyama J, Mikuni T, Yasuda R. Virus-mediated genome editing via homology-directed repair in mitotic and postmitotic cells in mammalian brain. Neuron. 2017;96:755\u201368.","journal-title":"Neuron"},{"key":"624_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","volume":"5","author":"KK Gadalla","year":"2017","unstructured":"Gadalla KK, Vudhironarit T, Hector RD, Sinnett S, Bahey NG, Bailey ME, et al. Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome. Mol Ther-Methods Clin Dev. 2017;5:180\u201390.","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"624_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1042\/BST0380498","volume":"38","author":"S Cobb","year":"2010","unstructured":"Cobb S, Guy J, Bird A. Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans. 2010;38:498\u2013506.","journal-title":"Biochem Soc Trans"},{"key":"624_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/104303401450988","volume":"12","author":"A Auricchio","year":"2001","unstructured":"Auricchio A, Hildinger M, O\u2019Connor E, Gao GP, Wilson JM. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther. 2001;12:71\u20136.","journal-title":"Hum Gene Ther"},{"key":"624_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol. 2015;33:102.","journal-title":"Nat Biotechnol"},{"key":"624_CR25","unstructured":"Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE et al. (eds). Current Protocols in Molecular Biology. John Wiley & Son: Hoboken, NJ, USA, 2000."},{"key":"624_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","volume":"33","author":"J Park","year":"2017","unstructured":"Park J, Lim K, Kim SJ, Bae S. Cas-analyzer: an online tool for assessing genome editing results using NGS data. Bioinformatics. 2017;33:286\u20138.","journal-title":"Bioinformatics"},{"key":"624_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/hmg\/ddv496","volume":"25","author":"K Brown","year":"2016","unstructured":"Brown K, Selfridge J, Lagger S, Connelly J, De Sousa D, Kerr A, et al. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum Mol Genet. 2016;25:558\u201370.","journal-title":"Hum Mol Genet"},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J. CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med. 2018;24:927.","journal-title":"Nat Med"},{"key":"624_CR29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","volume":"19","author":"M Thomas","year":"1999","unstructured":"Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092\u2013100.","journal-title":"Mol Cell Biol"},{"key":"624_CR30","doi-asserted-by":"crossref","unstructured":"Le TTH, Tran NT, Dao TML, Nguyen DD, Do DH, Ha LT, et al. Efficient and precise CRISPR\/Cas9-mediated MECP2 modifications in human induced pluripotent stem cells. Front Genet. 2019. 10.10.3389\/fgene.2019.00625.","DOI":"10.3389\/fgene.2019.00625"},{"key":"624_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/crispr.2018.0047","volume":"2","author":"M Martufi","year":"2018","unstructured":"Martufi M, Good RB, Rapiteanu R, Schmidt T, Patili E, Tvermosegaard K, et al. Single-step, high-efficiency CRISPR-Cas9 genome editing in primary human disease-derived fibroblasts. CRISPR J. 2018;2:31\u201340.","journal-title":"CRISPR J"},{"key":"624_CR32","doi-asserted-by":"publisher","first-page":"e0165499","DOI":"10.1371\/journal.pone.0165499","volume":"11","author":"N Xie","year":"2016","unstructured":"Xie N, Gong H, Suhl JA, Chopra P, Wang T, Warren ST. Reactivation of FMR1 by CRISPR\/Cas9-mediated deletion of the expanded CGG-repeat of the fragile X chromosome. PLoS ONE 2016;11:e0165499.","journal-title":"PLoS ONE"},{"key":"624_CR33","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713\u201322.","journal-title":"N Engl J Med"},{"key":"624_CR34","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI78167","volume":"125","author":"LM Lombardi","year":"2015","unstructured":"Lombardi LM, Baker SA, Zoghbi HY. MECP2 disorders: from the clinic to mice and back. J Clin Investig. 2015;125:2914\u201323.","journal-title":"J Clin Investig"},{"key":"624_CR35","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1093\/hmg\/ddr110","volume":"20","author":"WJ Bowers","year":"2011","unstructured":"Bowers WJ, Breakefield XO, Sena-Esteves M. Genetic therapy for the nervous system. Hum Mol Genet. 2011;20:R28\u201341.","journal-title":"Hum Mol Genet"},{"key":"624_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.00008-08","volume":"21","author":"S Daya","year":"2008","unstructured":"Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev. 2008;21:583\u201393.","journal-title":"Clin Microbiol Rev"},{"key":"624_CR37","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial. Lancet. 2007;369:2097\u2013105.","journal-title":"Lancet"},{"key":"624_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59.","journal-title":"Nat Biotechnol"},{"key":"624_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/rmv.1762","volume":"23","author":"S Hareendran","year":"2013","unstructured":"Hareendran S, Balakrishnan B, Sen D, Kumar S, Srivastava A, Jayandharan GR. Adeno\u2010associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them. Rev Med Virol. 2013;23:399\u2013413.","journal-title":"Rev Med Virol"},{"key":"624_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","volume":"5","author":"SE Sinnett","year":"2017","unstructured":"Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, et al. Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery. Mol Ther Methods Clin Dev. 2017;5:106\u201315.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"624_CR41","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/biot.201400046","volume":"9","author":"E Sen\u00eds","year":"2014","unstructured":"Sen\u00eds E, Fatouros C, Gro\u00dfe S, Wiedtke E, Niopek D, Mueller AK, et al. CRISPR\/Cas9\u2010mediated genome engineering: an adeno\u2010associated viral (AAV) vector toolbox. Biotechnol J. 2014;9:1402\u201312.","journal-title":"Biotechnol J"},{"key":"624_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.celrep.2017.06.064","volume":"20","author":"RO Bak","year":"2017","unstructured":"Bak RO, Porteus MH. CRISPR-mediated integration of large gene cassettes using AAV donor vectors. Cell Rep. 2017;20:750\u20136.","journal-title":"Cell Rep."},{"key":"624_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","volume":"10","author":"J Saraiva","year":"2016","unstructured":"Saraiva J, Nobre RJ, Pereira de Almeida L. Gene therapy for the CNS using AAVs: the impact of systemic delivery by AAV9. J Control Release. 2016;10:94\u2013109.","journal-title":"J Control Release"},{"key":"624_CR44","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/gt.2012.101","volume":"20","author":"SJ Gray","year":"2013","unstructured":"Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Jude Samulski R. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 2013;20:450\u20139.","journal-title":"Gene Ther"},{"key":"624_CR45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s13311-014-0299-5","volume":"11","author":"CA Maguire","year":"2014","unstructured":"Maguire CA, Ramirez SH, Merkel SF, Sena-Esteves M, Breakefield XO. Gene therapy for the nervous system: challenges and new strategies. Neurotherapeutics 2014;11:817\u201339.","journal-title":"Neurotherapeutics"},{"key":"624_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","volume":"12","author":"H B\u00fcning","year":"2019","unstructured":"B\u00fcning H, Srivastava A. Capsid modifications for targeting and improving the efficacy of AAV Vectors. Mol Ther-Methods Clin Dev. 2019;12:248\u201365.","journal-title":"Mol Ther-Methods Clin Dev"},{"key":"624_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","volume":"25","author":"G-X Ruan","year":"2017","unstructured":"Ruan G-X, Barry E, Yu D, Lukason M, Cheng SH, Scaria A. CRISPR\/Cas9-mediated genome editing as a therapeutic approach for leber congenital amaurosis 10. Mol Ther. 2017;25:331\u201341.","journal-title":"Mol Ther."},{"key":"624_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep42127","volume":"7","author":"H Gong","year":"2017","unstructured":"Gong H, Liu M, Klomp J, Merrill BJ, Rehman J, Malik AB. Method for dual viral vector mediated CRISPR-Cas9 gene disruption in primary human endothelial cells. Sci Rep. 2017;7:42127.","journal-title":"Sci Rep."},{"key":"624_CR49","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/gt.2015.53","volume":"22","author":"HW Chu","year":"2015","unstructured":"Chu HW, Rios C, Huang C, Wesolowska-Andersen A, Burchard EG, O\u2019Connor BP, et al. CRISPR\u2013Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18. Gene Ther. 2015;22:822.","journal-title":"Gene Ther"},{"key":"624_CR50","doi-asserted-by":"publisher","first-page":"e0182974","DOI":"10.1371\/journal.pone.0182974","volume":"12","author":"O Voets","year":"2017","unstructured":"Voets O, Tielen F, Elstak E, Benschop J, Grimbergen M, Stallen J, et al. Highly efficient gene inactivation by adenoviral CRISPR\/Cas9 in human primary cells. PloS ONE. 2017;12:e0182974.","journal-title":"PloS ONE"},{"key":"624_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47:497\u2013510.","journal-title":"Mol Cell"},{"key":"624_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox DBT, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21:121.","journal-title":"Nat Med"},{"key":"624_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09716-x","volume":"7","author":"T Ishizu","year":"2017","unstructured":"Ishizu T, Higo S, Masumura Y, Kohama Y, Shiba M, Higo T, et al. Targeted genome replacement via homology-directed repair in non-dividing cardiomyocytes. Sci Rep. 2017;7:9363.","journal-title":"Sci Rep."},{"key":"624_CR54","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/carcin\/bgp117","volume":"30","author":"M Keimling","year":"2009","unstructured":"Keimling M, Wiesm\u00fcller L. DNA double-strand break repair activities in mammary epithelial cells\u2013\u2013influence of endogenous p53 variants. Carcinogenesis. 2009;30:1260\u20138.","journal-title":"Carcinogenesis"},{"key":"624_CR55","doi-asserted-by":"publisher","first-page":"160225","DOI":"10.1098\/rsob.160225","volume":"6","author":"S Moureau","year":"2016","unstructured":"Moureau S, Luessing J, Harte EC, Voisin M, Lowndes NF. A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining. Open Biol. 2016;6:160225.","journal-title":"Open Biol"},{"key":"624_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncb3452","volume":"19","author":"N Hustedt","year":"2016","unstructured":"Hustedt N, Durocher D. The control of DNA repair by the cell cycle. Nat Cell Biol. 2016;19:1\u201394.","journal-title":"Nat Cell Biol"},{"key":"624_CR57","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ IHry","year":"2018","unstructured":"IHry RJ, Worringer KA, Salick MR, Frias E, Ho D, Theriault K, et al. p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells. Nat Med. 2018;24:939.","journal-title":"Nat Med"},{"key":"624_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0578-6","volume":"10","author":"A Conti","year":"2018","unstructured":"Conti A, Di Micco R. p53 activation: a checkpoint for precision genome editing? Genome Med. 2018;10:66.","journal-title":"Genome Med"},{"key":"624_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2015;33:187\u201397.","journal-title":"Nat Biotechnol"}],"updated-by":[{"DOI":"10.1038\/s41431-023-01290-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000}}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0624-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T19:04:13Z","timestamp":1675537453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-0624-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-0624-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41431-023-01290-3","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update in the Acknowledgment section.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41431-023-01290-3","URL":"https:\/\/doi.org\/10.1038\/s41431-023-01290-3","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Azienda Ospedaliera Universitaria Senese Ethics Committee, Prot Name CRI, Prot n 12362_2018.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was provided to the patients before blood drowning and skin biopsies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}